Navigation Links
Talyst Moves Patient Safety and Inventory Control Beyond the Hospital
Date:12/7/2008

BELLEVUE, Wash., Dec. 7 /PRNewswire/ -- Talyst, a leader in pharmacy automation, today demonstrated InSite(TM), its innovative hardware and software system designed to help central pharmacies provide unparalleled support for extended care environments with the use of remote dispensing technologies. The products were developed in response to hospital pharmacies' increasing need to implement safer, more cost-effective ways to service the long-term care and correctional care environments they support.

InSite is being demonstrated this week at the American Society of Health-System Pharmacist (ASHP) Midyear Clinical Meeting in Orlando, FL.

"Talyst is committed to engineering a safer pharmacy in all healthcare environments. We have a strong history of delivering innovative automation solutions to our hospital pharmacy customers, and InSite is a natural extension of that innovation," noted Carla Corkern, chief executive officer of the company. "Talyst was the first to provide inventory and workflow management control to all medication inventory locations, including support for multiple hospitals. With Talyst InSite, we are the first to extend that control to extended care environments managed by the hospital or integrated delivery network."

A New Model for Remote Medication Management

The InSite Remote Dispensing System allows the central pharmacy to place a secure, automated medication dispensing unit at each facility they service. With InSite, medications are already at the facility and pharmacist-approved medication orders are immediately available for dispensing in patient-specific, multi-dose packaging.

The innovative InSite system helps eliminate the need to create time-consuming, waste-prone medication blister packs. It also enables faster First Doses, gives nursing staff more time for other tasks, and allows down-to-the-dose accountability at each facility.

With centralized inventory monitoring, InSite requires far fewer scheduled deliveries and special courier runs from the central pharmacy in order to meet the changing needs of the facilities.

"Healthcare system pharmacies are increasingly looking for ways to improve the safety and efficiency of their pharmacy operations beyond the traditional in-patient settings," Corkern continued. "In a challenging economy, a growing number of hospital pharmacies are being asked to improve cost controls and find new revenue sources. The InSite system improves the partnership between central pharmacies and the facilities they support, and enables new opportunities for growth and safety improvements," she concluded.

About Talyst

Talyst is engineering a safer pharmacy. The company provides automated systems to hospitals, long-term care facilities and correctional facilities to improve patient safety and dispensing accuracy while reducing costs and increasing productivity. The Talyst solution uses innovative software and a suite of proven hardware components to package, barcode, store and track medication inventories.

Talyst is an award-winning company with more than 300 hospital and integrated healthcare companies. The company is ranked in the "Inc. 500" national list of fastest-growing private companies, ranked number two on the Deloitte "Fast 50" Technology Companies in Washington State, and was listed as one of Fast Company magazine's "Fast 50 Reader Favorites", honoring innovative, progressive enterprises.

For more information, call 877-4-Talyst (877-482-5978) or visit www.talyst.com, www.talyst.com/ltc or see www.talyst.com/corrections.

Talyst and InSite are trademarks of Talyst Inc. Other trade names are the property of their respective owners.


'/>"/>
SOURCE Talyst
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Talyst Unveils InSite for Long-Term Care
2. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
3. Catalyst mystery unlocked
4. CATalyst Council Forms to Address Feline Health Care
5. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
6. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
7. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
8. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
9. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
10. CATalyst Summit Declared a Success: Its All About the Cat!
11. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser ... Cancer Institute. For Betsy, the clinical trial has been life-saving as she has ... worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... ... ... and enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is ... a devoted woman of faith. , “Becoming a parent changes you. In my case, ... for years, but actually doing it might have been a while in coming if it ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
Breaking Medicine Technology: